drugset / Trial / NCT00641511
Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)
Phase 2
Withdrawn
Michael E. DeBakey VA Medical Center
Acorda Therapeutics · collabRalph H. Johnson VA Medical Center · collabTuscaloosa Veterans Affairs Medical Center · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Assess the effect of nepicastat in the treatment of in Post Traumatic Stress Disorder (PTSD) in conflict or combat zone experienced veterans, in comparison to placebo.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-09
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nepicastat | Small molecule | 120 mg | Oral |